{ "case_number": "CAC-UDRP-108642", "time_of_filling": "2026-05-14 10:00:03", "domain_names": [ "novartisus.online" ], "case_administrator": "Olga Dvořáková (Case admin)", "complainant": [ "Novartis AG" ], "complainant_representative": "Abion GmbH", "respondent": [ "DCN Realty" ], "respondent_representative": null, "factual_background": "

The Complainant, Novartis AG, is a global pharmaceutical and healthcare group headquartered in Basel, Switzerland. It was created in 1996 through a merger of Ciba-Geigy and Sandoz. In 2025, Novartis achieved net sales of USD 54.5 billion and a total net income of USD 14 billion, and employed 75,267 full-time equivalent employees as of 31 December 2025.<\/p>\n

The Complainant is the owner of the registered trademark NOVARTIS in numerous jurisdictions worldwide and operates its official website at www.novartis.com. The Complainant also owns the domain names <novartisus.com> (registered on 15 December 2000) and <novartis-us.com> (registered on 5 December 2004).<\/p>\n

The Novartis Group has maintained a presence in the Philippines through Novartis Healthcare Philippines, Inc. since 1996.<\/p>\n

The disputed domain name <novartisus.online> was registered on 23 January 2026. On 28 January 2026, it resolved to a registrar parking page. The disputed domain name is currently inactive.<\/span><\/p>\n

On 28 January 2026, the Complainant sent a cease-and-desist letter to the Respondent via the Registrar. The Complainant also sent the cease-and-desist letter to the Respondent via the Registrar's online contact form. The Complainant sent a further reminder on 13 February 2026, but there was apparently no response.<\/span><\/p>", "other_legal_proceedings": "

The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "

The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.
No administratively compliant Response has been filed.<\/p>", "rights": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "

The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "

The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Flip Petillion" ], "date_of_panel_decision": "2026-06-26 00:00:00", "informal_english_translation": "

The Complainant is the holder of the registered word mark NOVARTIS in numerous jurisdictions worldwide, including the International trademark NOVARTIS No. 1349878, registered on 29 November 2016, designating inter alia the Philippines, the United States of America (\"United States\") and the European Union and covering classes <\/span>9, 10, 41, 42, 44 and 45.<\/div>", "decision_domains": { "novartisus.online": "TRANSFERRED" }, "panelist": null, "panellists_text": null }